|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003313,
umls-concept:C0014792,
umls-concept:C0024141,
umls-concept:C0030705,
umls-concept:C0033453,
umls-concept:C0205210,
umls-concept:C0205421,
umls-concept:C0229671,
umls-concept:C0679823,
umls-concept:C0700364,
umls-concept:C1441672,
umls-concept:C1457887,
umls-concept:C1609982,
umls-concept:C2266866
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1998-4-14
|
|
pubmed:abstractText |
To investigate whether participation of factor B (FB) in immune complex transport might explain long periods of clinical remissions in a homozygous C2-deficient patient with systemic lupus erythematosus (SLE) treated regularly with plasma infusions.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
427-34
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9506570-Antibodies,
pubmed-meshheading:9506570-Antigen-Antibody Complex,
pubmed-meshheading:9506570-Complement C1q,
pubmed-meshheading:9506570-Complement C2,
pubmed-meshheading:9506570-Complement C4,
pubmed-meshheading:9506570-Complement Factor B,
pubmed-meshheading:9506570-Erythrocytes,
pubmed-meshheading:9506570-Humans,
pubmed-meshheading:9506570-Lupus Erythematosus, Systemic,
pubmed-meshheading:9506570-Time Factors
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Participation of factor B in residual immune complex red cell binding activity observed in serum from a C2-deficient systemic lupus erythematosus patient may delay the appearance of clinical symptoms.
|
|
pubmed:affiliation |
The National University Hospital, Landspítalinn, Reykjavik, Iceland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
